Risk of breast or ovarian cancer in family members who do not carry the BRCA1 or BRCA2 family mutation: Findings from the EMBRACE study.

被引:0
|
作者
Girardi, Fable
Barnes, Daniel R.
Barrowdale, Daniel
Frost, Debra
Easton, Douglas F.
Antoniou, Antonis C.
机构
关键词
D O I
10.1200/JCO.2017.35.15_suppl.1558
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1558
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations
    Ane Y. Steffensen
    Lars Jønson
    Bent Ejlertsen
    Anne-Marie Gerdes
    Finn C. Nielsen
    Thomas V. O. Hansen
    Familial Cancer, 2010, 9 : 283 - 287
  • [22] Analysis of BRCA1 and BRCA2 mutations in an Iranian family with hereditary breast and ovarian cancer syndrome
    Moslehi, R
    Kariminejad, MH
    Ghaffari, V
    Narod, S
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 117A (03) : 304 - 305
  • [23] Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations
    Steffensen, Ane Y.
    Jonson, Lars
    Ejlertsen, Bent
    Gerdes, Anne-Marie
    Nielsen, Finn C.
    Hansen, Thomas V. O.
    FAMILIAL CANCER, 2010, 9 (03) : 283 - 287
  • [24] Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Joanne Kotsopoulos
    Jan Lubinski
    Leonardo Salmena
    Henry T Lynch
    Charmaine Kim-Sing
    William D Foulkes
    Parviz Ghadirian
    Susan L Neuhausen
    Rochelle Demsky
    Nadine Tung
    Peter Ainsworth
    Leigha Senter
    Andrea Eisen
    Charis Eng
    Christian Singer
    Ophira Ginsburg
    Joanne Blum
    Tomasz Huzarski
    Aletta Poll
    Ping Sun
    Steven A Narod
    Breast Cancer Research, 14
  • [25] Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2
    S. M. Domchek
    M. M. Gaudet
    J. E. Stopfer
    M. H. Fleischaut
    J. Powers
    N. Kauff
    K. Offit
    K. L. Nathanson
    M. Robson
    Breast Cancer Research and Treatment, 2010, 119 : 409 - 414
  • [26] Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2
    Domchek, S. M.
    Gaudet, M. M.
    Stopfer, J. E.
    Fleischaut, M. H.
    Powers, J.
    Kauff, N.
    Offit, K.
    Nathanson, K. L.
    Robson, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (02) : 409 - 414
  • [27] Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Timothy R Rebbeck
    Susan M Domchek
    Breast Cancer Research, 10
  • [28] Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
    Kotsopoulos, Joanne
    Gronwald, Jacek
    Huzarski, Tomasz
    Aeilts, Amber
    Armel, Susan Randall
    Karlan, Beth
    Singer, Christian
    Eisen, Andrea
    Tung, Nadine
    Olopade, Olufunmilayo
    Bordeleau, Louise
    Eng, Charis
    Foulkes, William
    Neuhausen, Susan
    Cullinane, Carey
    Pal, Tuya
    Fruscio, Robert
    Lubinski, Jan
    Metcalfe, Kelly
    Sun, Ping
    Narod, Steven
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (02) : 257 - 264
  • [29] Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
    Joanne Kotsopoulos
    Jacek Gronwald
    Tomasz Huzarski
    Amber Aeilts
    Susan Randall Armel
    Beth Karlan
    Christian F. Singer
    Andrea Eisen
    Nadine Tung
    Olufunmilayo Olopade
    Louise Bordeleau
    Charis Eng
    William D. Foulkes
    Susan L. Neuhausen
    Carey A. Cullinane
    Tuya Pal
    Robert Fruscio
    Jan Lubinski
    Kelly Metcalfe
    Ping Sun
    Steven A. Narod
    Breast Cancer Research and Treatment, 2023, 201 : 257 - 264
  • [30] Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Kelly Metcalfe
    Henry T. Lynch
    Parviz Ghadirian
    Nadine Tung
    Charmaine Kim-Sing
    Olufunmilayo I. Olopade
    Susan Domchek
    Andrea Eisen
    William D. Foulkes
    Barry Rosen
    Danny Vesprini
    Ping Sun
    Steven A. Narod
    Breast Cancer Research and Treatment, 2011, 127 : 287 - 296